摘要
Nef是只在灵长类动物慢病毒中表达的一种辅助蛋白。它作为一种接合/支架蛋白,在与细胞蛋白相互作用的时,是没有酶活性的。Nef的细胞内功能在很大程度上能够解释许多AIDS 病的致病作用。尽管缺乏已知的分泌途径,但我们可以检测出HIV-1感染患者血浆中Nef 5-10 ng/ml的浓度变化。值得注意的是,AIDS患者血浆中Nef蛋白水平与病毒载量和CD4 + T淋巴细胞的数量无关,即使进行抗逆转录病毒治疗也是如此。本文对Nef如何从 HIV-1感染细胞转移至旁边细胞以及在不同类型细胞的胞外Nef的影响进行了概括总结。总之,大量实验证明,Nef在艾滋病的发病机制中起重要作用。因此,对Nef抑制药物的识别研究将有助于在目前抗逆转录病毒疗法基础上建立新的治疗方法。
关键词: ADAM17,细胞信号转导,外泌体,HIV-1感染,纳米管,Nef。
图形摘要
Current Drug Targets
Title:The Contribution of Extracellular Nef to HIV-Induced Pathogenesis
Volume: 17 Issue: 1
Author(s): Eleonora Olivetta, Claudia Arenaccio, Francesco Manfredi, Simona Anticoli and Maurizio Federico
Affiliation:
关键词: ADAM17,细胞信号转导,外泌体,HIV-1感染,纳米管,Nef。
摘要: Nef is an accessory protein expressed exclusively in primate lentiviruses. It is devoid of enzymatic activities while interacting with several cell proteins as an adaptor/scaffold protein. Intracellular functions of Nef largely account for many pathogenic effects observed in AIDS disease. Nef, despite lacking known secretory pathways, can be detected in plasma of HIV-1-infected patients at the concentration varing from 5 to 10 ng/ml. Remarkably, the levels of Nef in plasma of HIV patients do not correlate with viral load or number of CD4+ T lymphocytes, and persist during antiretroviral therapy. Here, we review literature data describing how Nef can be transmitted from HIV-1- infected cells to bystander ones, and the effects of extracellular Nef in different cell types. Overall, large part of experimental evidences supports the idea that extracellular Nef plays a relevant role in AIDS pathogenesis. Hence, efforts focused on the identification of Nef-inhibiting drugs would be of relevance to establish new therapeutic approaches supporting current antiretroviral therapies.
Export Options
About this article
Cite this article as:
Eleonora Olivetta, Claudia Arenaccio, Francesco Manfredi, Simona Anticoli and Maurizio Federico , The Contribution of Extracellular Nef to HIV-Induced Pathogenesis, Current Drug Targets 2016; 17 (1) . https://dx.doi.org/10.2174/1389450116666151001110126
DOI https://dx.doi.org/10.2174/1389450116666151001110126 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Assessing Combinations of Cytotoxic Agents Using Leukemia Cell Lines
Current Drug Targets In Silico Insights on GD2 : A Potential Target for Pediatric Neuroblastoma
Current Topics in Medicinal Chemistry Possible Physiopathological Effects of the Transglutaminase Activity on the Molecular Mechanisms Responsible for Human Neurodegenerative Diseases
Recent Patents on CNS Drug Discovery (Discontinued) Hormetic Potential of Sulforaphane (SFN) in Switching Cells’ Fate Towards Survival or Death
Mini-Reviews in Medicinal Chemistry Design, Synthesis, and Anti-Neuroinflammatory Activity of Amide- Containing Dithiolethiones
Medicinal Chemistry Eremurus spectabilis, Rich Source of Isoorientin: Isolation, Quantification and Anti-Cancer Activity on SH-SY5Y Neuroblastoma Cells
Current Pharmaceutical Analysis Protein Tyrosine Signaling and its Potential Therapeutic Implications in Carcinogenesis
Current Pharmaceutical Design Histone Deacetylase Inhibitors: Molecular and Biological Activity as a Premise to Clinical Application
Current Drug Metabolism Pharmacological Modulation of Sphingolipids and Role in Disease and Cancer Cell Biology
Mini-Reviews in Medicinal Chemistry Gamma-Secretase as a Pharmacological Target in Alzheimer Disease Research: When, Why and How?
Current Pharmaceutical Design Biosafety of Herpesvirus Vectors
Current Gene Therapy Cancer-Targeted Oncolytic Adenoviruses for Modulation of the Immune System
Current Cancer Drug Targets MicroRNAs in Cancer Therapy: From Bench to Bedside
Current Cancer Therapy Reviews MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Current Drug Targets Metabolic Analysis of Triptolide Microspheres in Human, Dog, Rabbit and Rat Liver Microsomes with UPLC-MS/MS Method
Current Pharmaceutical Analysis Cigarette Smoke-Induced Oxidant Stress in the Lung, the Unfolded Protein Response, and COPD
Current Respiratory Medicine Reviews Phycobilins and Phycobiliproteins Used in Food Industry and Medicine
Mini-Reviews in Medicinal Chemistry The PI3K-AKt-mTOR Pathway and New Tools to Prevent Acquired Hormone Resistance in Breast Cancer
Current Pharmaceutical Biotechnology Benefit of 13-desmethyl Spirolide C Treatment in Triple Transgenic Mouse Model of Alzheimer Disease: Beta-Amyloid and Neuronal Markers Improvement
Current Alzheimer Research Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
Current Pharmaceutical Design